| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.004 |